Search

Dawei Sheng

from Fremont, CA
Age ~59
Get Report
Also known as:
Dawei Lin, Damei Sheng, Sheng Dawei, Lin Dawei, Lin Da Wei, Brad Sims
Phone and address:
4136 Coralline Ct, Fremont, CA 94555
Related to:
Jowen U Lin, 48Alex Lin, 43Lin H Lee, 79Linhai Ding, 34Linda Lin, 51Carol Lin, 79
Connected to:
Aaron Sheng, 31Alex K Sheng, 61Austin L Sheng, 31Bin Sheng, 57Christine I Sheng, 53Hainan Sheng, 39Henry P Sheng, 93Holly C Sheng, 45Hsueh Sheng, 45Ke Sheng, 55

Dawei Sheng Phones & Addresses

  • 4136 Coralline Ct, Fremont, CA 94555
  • 158 Silo Hill Rd, Madison, AL 35758 (256) 325-2469
  • 2310 Rock St, Mountain View, CA 94043 (650) 938-5641
  • 2403 Bishop Ave, Ann Arbor, MI 48105
  • Portland, OR
  • 3927 Southampton Ter, Fremont, CA 94555

Publications

Us Patents

Polymer Conjugates Of Therapeutic Peptides

View page
US Patent:
20110166063, Jul 7, 2011
Filed:
Sep 17, 2009
Appl. No.:
13/119297
Inventors:
Mary J. Bossard - Madison AL, US
Steven O. Roczniak - Greensboro NC, US
Harold Zappe - Harvest AL, US
Yujun Wang - Madison AL, US
Ping Zhang - Madison AL, US
Dawei Sheng - Madison AL, US
C. Simone Jude-Fishburn - Redwood City CA, US
Elizabeth Louise Minamitani - Lacey's Spring AL, US
Xiaofeng Liu - Union City CA, US
Haim Moskowitz - San Diego CA, US
Dennis G. Fry - Huntsville AL, US
Cherie F. Ali - Burlingame CA, US
Christine Taylor Brew - Pacifica CA, US
Assignee:
Nektar Therapeutics - San Francisco CA
International Classification:
A61K 38/28
A61K 38/16
A61K 38/08
A61K 38/06
A61K 38/07
A61K 38/10
C07K 5/08
C07K 7/06
C07K 7/08
C07K 14/00
A61P 3/10
US Classification:
514 59, 514 213, 514 212, 514 217, 514 216, 514 219, 514 218, 514 215, 530303, 530331, 530330, 530329, 530328, 530327, 530326, 530324, 530350
Abstract:
The invention provides peptides that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the peptide not attached to the water-soluble oligomer.

Polymer Conjugates Of Ziconotide Peptides

View page
US Patent:
20110171163, Jul 14, 2011
Filed:
Sep 17, 2009
Appl. No.:
13/119232
Inventors:
Dawei Sheng - Madison AL, US
Harold Zappe - Harvest AL, US
C. Simone Jude-Fishburn - Redwood City CA, US
Steven O. Roczniak - Greensboro NC, US
Mary J. Bossard - Madison AL, US
Assignee:
Nektar Therapeutics - San Francisco CA
International Classification:
A61K 47/48
C08G 65/48
A61P 29/00
US Classification:
424 7817, 525 541
Abstract:
The invention provides peptides that are chemically modified by covalent attachment of a water soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the peptide not attached to the water soluble oligomer.

Conjugates Pf Small-Interfering Nucleic Acids

View page
US Patent:
20120100096, Apr 26, 2012
Filed:
Aug 19, 2008
Appl. No.:
12/737833
Inventors:
Samuel P. McManus - Huntsville AL, US
Timothy A. Riley - Huntsville AL, US
Sean M. Culbertson - Gurley AL, US
Antoni Kozlowski - Huntsville AL, US
Dennis G. Fry - Huntsville AL, US
Xuejun Yuan - Huntsville AL, US
Dawei Sheng - Madison AL, US
Vidula R. Dixit - Madison AL, US
Assignee:
Nektar Therapeutics - San Francisco CA
International Classification:
A61K 47/48
C07H 1/00
C08G 65/335
C07H 21/00
C07H 21/02
US Classification:
424 783, 536 245, 514 44 A, 525 542
Abstract:
The present invention relates to conjugates of small-interfering nucleic acids (siNA). Compositions of siNA suited for administration to a patient are described. Methods for delivering the compositions are also described.

Methods And Compositions For Detecting One Or More Target Agents Using Tracking Components

View page
US Patent:
20120269728, Oct 25, 2012
Filed:
Jun 21, 2007
Appl. No.:
11/812691
Inventors:
I-Min M. Jen - Sunnyvale CA, US
Mark O. Trulson - San Jose CA, US
Kilian Dill - La Honda CA, US
Marc R. Labgold - Reston VA, US
Dawei Sheng - Mountain View CA, US
George G. Jokhadze - Mountain View CA, US
Chandramohan V. Ammini - Mountain View CA, US
Peter Lobban - Los Altos Hills CA, US
Assignee:
Antara BioSciences Inc. - Mountain View CA
International Classification:
G01N 23/00
G01N 33/53
G01N 21/76
G01N 33/567
G01N 27/72
A61K 49/00
A61B 5/07
C12Q 1/68
G01N 33/569
G01N 30/02
US Classification:
424 91, 435 71, 436501, 436 94, 436 86, 600302, 435 611, 435 721
Abstract:
The present invention provides devices and methods for real time detection of target agents in a sample. These devices utilize tracking technology and selective binding to allow the identification of one or more target agents in a sample, and preferably in a biological sample. The present invention provides specific embodiments employing radio frequency identification devices.

Fluorescent Energy Transfer Labeled Nucleic Acid Substrates And Methods Of Use Thereof

View page
US Patent:
20050250134, Nov 10, 2005
Filed:
Mar 1, 2005
Appl. No.:
11/070871
Inventors:
Dawei Sheng - Mountain View CA, US
Marcia Tan - Palo Alto CA, US
Robert Larsen - Alameda CA, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
Methods and compositions for detecting a target nucleic acid in a sample are provided. Also provided are methods and compositions for detecting a plurality of target nucleic acids in a sample. Sets of components for use in a subject method are provided; as well as compositions that include a subject set. The invention further provides kits and systems for practicing the subject methods

Conjugates Of A Factor Viii Moiety Having An Oxime-Containing Linkage

View page
US Patent:
20210369817, Dec 2, 2021
Filed:
Jul 21, 2017
Appl. No.:
16/319759
Inventors:
- San Francisco CA, US
Dawei Sheng - Fremont CA, US
International Classification:
A61K 38/37
A61K 47/54
A61K 47/60
C08G 65/332
C08G 65/333
C08G 65/331
Abstract:
The present disclosure provides conjugates comprising a Factor VIII moiety covalently attached via an oxime-containing linkage to a water-soluble polymer, such as for example, a polyethylene glycol polymer. Methods for preparing and for administering such conjugates, are also provided, as are water-soluble polymer oxyamine reagents useful for preparing the subject conjugates, among other things.

Polymer Conjugates Of Therapeutic Peptides

View page
US Patent:
20190070251, Mar 7, 2019
Filed:
Apr 28, 2017
Appl. No.:
15/581348
Inventors:
- San Francisco CA, US
Steven O. Roczniak - Prescott AZ, US
Harold Zappe - Harvest AL, US
Yujun Wang - Fremont CA, US
Ping Zhang - Millbrae CA, US
Dawei Sheng - Fremont CA, US
C. Simone Jude-Fishburn - Redwood City CA, US
Elizabeth Louise Minamitani - Lacey's Spring AL, US
Xiaofeng Liu - Belmont CA, US
Haim Moskowitz - San Diego CA, US
Dennis G. Fry - Pacifica CA, US
Cherie F. Ali - Burlingame CA, US
Christine Taylor Brew - Pacifica CA, US
International Classification:
A61K 38/10
A61K 38/28
A61K 47/60
A61K 47/61
A61K 38/16
Abstract:
The invention provides peptides that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the peptide not attached to the water-soluble oligomer.

Polymer Conjugates Of Therapeutic Peptides

View page
US Patent:
20160022828, Jan 28, 2016
Filed:
Mar 20, 2015
Appl. No.:
14/664582
Inventors:
- San Francisco CA, US
Steven O. Roczniak - Greensboro NC, US
Harold Zappe - Harvest AL, US
Yujun Wang - Fremont CA, US
Ping Zhang - Millbrae CA, US
Dawei Sheng - Madison AL, US
C. Simone Jude-Fishburn - Redwood City CA, US
Elizabeth Louise Minamitani - Lacey's Spring AL, US
Xiaofeng Liu - Belmont CA, US
Haim Moskowitz - San Diego CA, US
Dennis G. Fry - Pacifica CA, US
Cherie F. Ali - Burlingame CA, US
Christine Taylor Brew - Pacifica CA, US
International Classification:
A61K 47/48
A61K 38/16
Abstract:
The invention provides peptides that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the peptide not attached to the water-soluble oligomer.
Control profile
Dawei Sheng from Fremont, CA, age ~59 Get Report